FindTrial
Sign In

A clinical study of and Ayurveda Syrup named Amrita Bindu Syrup in treating patients with long term heart burn and sour belch

An Open Label Pilot Clinical Study to assess the Efficacy and Safety of Amrita Bindu Syrup in Patients with Gastro Esophageal Reflux Disease (Gerd) in Managing Symptoms such as Heartburn, Regurgitation and Difficulty Swallowing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017357
Enrollment
100
Registered
2019-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: Amrita Bindu SSyrup: oral dose given 2 ml mixed with 30 ml luke warm water thrice daily after food given Control Intervention1: None: None

Sponsors

Clinfound Clinical Research Services PvtLtd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical Diagnosis of GERD Ready give Informed Consent Form

Exclusion criteria

Exclusion criteria: Patients who have undergone Gastric surgeries Known cases of Gastric and duodenal ulcers Patients with Gastric Malignancies Gastritis with others systemic disorders

Design outcomes

Primary

MeasureTime frame
The GERD-HRQL questionnaireTimepoint: Day 1 Day 15 Day 30—

Secondary

MeasureTime frame
Bloated Abdomen scoreTimepoint: Day 1 Day 15 Day 30;Constipation/Hard StoolTimepoint: Day 1 Day 15 Day 30;GERD Difficulty in Swallowing ScoreTimepoint: Day 1 Day 15 Day 30;GERD Heartburn ScoreTimepoint: Day 1 Day 15 Day 30;GERD Regurgitation ScoreTimepoint: Day 1 Day 15 Day 30—

Countries

India

Contacts

Public ContactDr Sreejith Sreekumar

Shankar Pharmacy

contact@shankarpharmacy.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026